October 30, 2008 - C. R. Bard Inc. today received approval from the FDA to market the Flair Endovascular Stent ...
Stents
This channel includes news and new technology innovations for stents, also called vascular scaffolds. Stents are used to help prop open a vessel treated by balloon angioplasty because of the barotrauma caused by the extreme stretching of vessel walls. The stent enables to vessel to heal in an open position with collapsing. Drug eluting stents (DES) are coated in anti-proliferative drugs to precent scar tissue growth which can cause restenosis and occlude the vessel. DES require antiplatelet therapy because the drug carrier polymer on DES can cause thrombus inside the stent, even years after treatment, which is why bare metal stents are still used in some patients. This page includes news on coronary stents, carotid stents, peripheral stents, bioresorbable stents, and renal stents.Â
October 27, 2008 - Medtronic Inc. last week announced the U.S. market launch of the Talent Thoracic Stent Graft on the ...
October 26, 2008
October 27, 2008 - Boston Scientific Corp. last week said the FDA approved its Carotid WALLSTENT Monorail ...
October 26, 2008Sponsored Content
Case Study | Baylor Scott and White Heart Hospital
While the current positive revolution in percutaneous coronary intervention (PCI) practice has been made possible by the ...
May 05, 2023October 21, 2008 - MIV Therapeutics Inc., a developer of coatings and drug-delivery systems for cardiovascular stents ...
October 20, 2008Feature | Dave Fornell
The stent wars continued at the Transcatheter Cardiovascular Therapeutics 2008 20th annual symposium last week with ...
October 20, 2008
The Ostial Pro Stent Positioning System is designed to facilitate precise stent implantation in coronary and renal ...
October 19, 2008October 20, 2008 – At TCT last week Abbott announced two-year data from 30 patients in its ABSORB clinical trial ...
October 19, 2008October 17, 2008 - Elixir Medical Corp. today announced results from three multicenter first-in-man studies of Novolimus ...
October 16, 2008October 17, 2008 - Boston Scientific Corp. announced results at TCT from an analysis of the HORIZONS-AMI trial showing a ...
October 16, 2008October 15, 2008 - Boston Scientific Corp. announced estimated U.S. market shares for September for its two drug-eluting ...
October 14, 2008October 15, 2008 - The new name and branding for MEDRAD’s interventional products division was unveiled to the public at ...
October 14, 2008October 15, 2008 – At TCT 2008, Boston Scientific Corp. announced 12-month left main and three-vessel disease subset ...
October 14, 2008October 15, 2008 – Two-year results from the ENDEAVOR-IV clinical trial show that the Endeavor drug-eluting stent (DES) ...
October 14, 2008October 15, 2008 – The latest update to an independently conducted pooled data analysis shows that Medtronic’s Endeavor ...
October 14, 2008October 14, 2008 – Medtronic released, at TCT 2008, new data from the ENDEAVOR clinical program that reinforces the ...
October 13, 2008© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now